Waltz Health, Fresenius Kabi partner for direct-to-payer biosimilar program
Digital health company Waltz Health is teaming up with drugmaker Fresenius Kabi to support direct-to-employer efforts for key biosimilar medications.
Today’s edition
Wednesday, September 30, 2026
Latest news
Browse the archiveHere’s how much insurers are cutting Medicare Advantage plans for 2027
Newly released CMS data gives the market its first comprehensive look at how insurers are adapting to continued pressure in the privatized Medicare program. A press release stressing “stability” didn’t soften the blow.
UnitedHealthcare names new president in latest leadership shuffle
Robert Hunter will focus on UnitedHealthcare’s “modernization agenda” in the new role. It’s the latest in a slew of leadership changes at UnitedHealth as the company works to restore its image.
Clinician shortage to double by 2040
The U.S. is on the brink of a healthcare workforce crisis, according to a new report from healthcare education company Covista. But it’s not too late to try to mitigate the impact.
How to slash the multi-billion dollar RCM Tax™: Leveling the playing field against payer AI
Discover how proactive clinical-financial workflows can protect your practice's bottom line.
OpenAI Gets Sued Over the Hugging Face Hack
A nonprofit in California is doing what Hugging Face has not—attempting to hold OpenAI legally accountable for the actions of its agents.
Anthropic Says It Discovered a Crispr-Like System. Now What?
“The experiments are still in the queue. The PR is already live,” says one expert.